Marijuana use associated with complications after heart attack or procedures

November 09, 2020

DALLAS, Nov. 9, 2020 -- Smoking marijuana increases the risk of complications after cardiovascular procedures, and marijuana users who had a heart attack or cardiac intervention were more likely to be readmitted to the hospital for recurrent heart attacks or coronary procedures, according to two preliminary studies to be presented at the American Heart Association's Scientific Sessions 2020. The meeting will be held virtually, Friday, November 13-Tuesday, November 17, 2020, and is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science for health care worldwide.

Using marijuana (also known as cannabis) is becoming more prevalent in the U.S., as numerous states have legalized it for recreational or medicinal use. However, research indicates marijuana has substantial risks and no benefits for cardiovascular health, and little is known about the safety of smoking marijuana for people with heart disease, according to a 2020 American Heart Association Scientific Statement. Two new studies, by separate researchers, explored how marijuana use affects patients with cardiovascular disease.

Not So Harmless: Marijuana Use and In-hospital Outcomes After Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (Presentation P1916)

Michigan researchers investigated whether patients who smoked marijuana are at an increased risk of complications after percutaneous coronary intervention (PCI) procedures compared with those who did not smoke marijuana. PCI, which includes angioplasty and stent placement, is a non-surgical procedure to open a blocked heart artery and restore blood flow to the heart.

"As marijuana is becoming more accessible across the U.S., there is a need for rigorous research to better understand the effects of marijuana use on cardiovascular health," said Sang Gune Yoo, M.D., internal medicine resident physician at the University of Michigan and lead author of the study.

Researchers used a state-wide registry of more than 113,000 patients in Michigan who underwent angioplasty from January 2013 to October 2016. Nearly 4,000 people, or 3.5% of those in the study, reported smoking marijuana within a month of a PCI procedure, however, they did not specify if the marijuana had been prescribed. Medical marijuana - prescribed use for a medical condition - has been legal in Michigan since 2008, and recreational marijuana was legalized in Michigan in 2018 (after the time period of this study).

Patients who smoked marijuana and underwent angioplasty were average age of 54, 79% male and 73% of them also smoked cigarettes. They had fewer traditional risk factors for heart disease, such as high cholesterol, diabetes or high blood pressure.

After adjusting for differences between patients who did or did not smoke marijuana, researchers found:"Although people who smoke marijuana may be at higher risk for complications such as stroke and post-PCI bleeding, this should not deter patients who use or have used marijuana from pursuing potentially life-saving PCI procedures," Yoo said. "As marijuana use continues to increase, medical professionals and patients should be aware of these increased risks of complications after PCI. Physicians should screen and counsel patients about marijuana prior to their procedure due to the risks of serious complications."

Senior study author Devraj Sukul, M.D., M.S., an interventional cardiologist at the University of Michigan, noted that, "understanding whether the effects of marijuana are dose-dependent or related to the method of intake are two important limitations of this study and remain important questions for future research."

Co-authors with Yoo and Sukul are Milan Seth, M.S., Thomas Earl, M.D., Cyril Ruwende, M.D., Ph.D., Milind Karve, M.D.; Ibrahim Shah, M.D.; Thomas Hill, M.D.; and Hitinder S. Gurm, M.D. Author disclosures are in the abstract.

The Blue Cross Blue Shield Michigan Cardiovascular Consortium (BMC2) coordinating center is supported by a grant from Blue Cross Blue Shield of Michigan to the University of Michigan. The sponsor had no role in the study design or decision to publish this work.

Note: Session EP.APS.11 - Social and Behavioral Risk Factors for Cardiovascular Disease

Prevalence, Trends and Impact of Cannabis Use on Hospitalizations With Prior Myocardial Infarction and Revascularization (Presentation P380)

This multi-center study assessed the prevalence and impact of marijuana use on hospital admissions for patients with previous heart attacks and revascularization procedures. Revascularization refers to restoring blood flow to the heart and includes non-surgical interventions such as percutaneous coronary intervention (PCI) as well as coronary artery bypass grafting (CABG). CABG is a surgical procedure to restore normal blood flow to a blocked coronary artery.

Researchers examined the National Inpatient Sample, the largest publicly accessible database in the U.S., to assess the rate of hospital admissions in patients with a history of previous heart attack, PCI and/or CABG, and self-identified marijuana users and non-users from 2007-2014. The database, which includes about 8 million hospital stays each year, does not include details about smoking or eating or other forms of marijuana consumption. Numerous states legalized or decriminalized medical and/or recreational marijuana during the study's time frame.

The analysis found:"There was an alarming rise in the trend of cannabis use among patients who have already had a heart attack or coronary revascularization procedure during the study period," said the study's lead author Rushik Bhuva, M.D., a cardiology fellow with the Wright Center for Community Health in Scranton, Pennsylvania. "Another concerning finding was that the frequency of recurrent heart attacks and cardiac interventions was higher among cannabis users, even though they were younger and had fewer risk factors for heart disease.

"Spreading awareness regarding the potential risk of recurrent heart attacks in middle-aged, African American and male cannabis users and screening them at an earlier age for potential risk factors of future heart attacks should be encouraged among clinicians," said Bhuva. "In addition, the role of medicinal cannabis, its benefits and potential risks with regards to cardiovascular management need to be validated in larger studies."
Study limitations included inability to access the mode and dose of cannabis consumption and lacking information about the time from cannabis use to cardiac event, whether use was recreational or medicinal and the lack of patient-level clinical information.

Co-authors with Bhuva are Rupak Desai, M.B.B.S.; Sandeep Singh, M.B.B.S.; Zainab J. Gandhi, M.B.B.S.; Faizan Ahmad Malik, M.D.; Virmitra G. Desai, M.B.B.S.; Vraj Patel, M.B.B.S.; Prince Khimani, M.B.B.S.; Falah Abu Hassan, M.B.B.S.; and Zarna Bambhroliya, M.B.B.S. Disclosures are in the abstract. There was no outside funding for the research.

Note: Session LF.APS.01 - Substance Use and CVD: Nicotine, Marijuana and Other Drugs

Additional Resources:

Multimedia, including an expert perspective video interview with Robert L. Page II Pharm.D. M.S.P.H. FAHA, Chair of the writing group for the American Heart Association Scientific Statement: Medical Marijuana, Recreational Cannabis, and Cardiovascular Health (August 2020) may be downloaded from the right column of the release link

Cannabis may be linked to strokes and heart rhythm disturbances in young people
Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association

For more news at AHA Scientific Sessions 2020, follow us on @HeartNews #AHA20.

Statements and conclusions of studies that are presented at the American Heart Association's scientific meetings are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers are available here, and the Association's overall financial information is available here.

About the American Heart Association

The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies, and share lifesaving resources and information. Connect with us on, Facebook, Twitter or by calling 1-800-AHA-USA1.

American Heart Association

Related Science Articles from Brightsurf:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.

Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.

Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.

Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.

World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.

PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.

Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.

Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.

Read More: Science News and Science Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to